Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study

Psychoneuroendocrinology

Volumn 33, Issue 7, 2008, Pages 1013-1022

  Hogervorst, Eef ^a   Huppert, Felicia ^b   Matthews, Fiona E ^d   Brayne, Carol ^c  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CTS Department of Public Health and Primary Care   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cognition; Dementia; FT4; Memory; Thyroid disorders; TSH

Indexed keywords

THYROID HORMONE; THYROTROPIN; THYROXINE;

AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; SEX; THYROID FUNCTION;

AGED; AGED, 80 AND OVER; AGING; COGNITION; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES; THYROTROPIN;

EID: 48149103375     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.05.008     Document Type: Article

References (43)

1. Annerbo S., Wahlund L.O., and Lokk J. The significance of TSH and homocysteine in the development of AD in MCI. Am. J. Alzheimers Dis. Other Demen. 21 3 (2006) 182-188
2. Bedford A., Foulds G.A., and Sheffield B.F. A new personal disturbance scale (DSSI/sAD). Br. J. Soc. Clin. Psychol. 15 (1976) 387-394
3. Cahill S., Clark M., Walsh C., O'Connell H., and Lawlor B. Dementia in primary care: the first survey of Irish general practitioners. Int. J. Geriatr. Psychiatry 21 4 (2006) 319-324
4. Clark P.M.S., and Price C.P. Enzyme amplified immunoassay:a new ultrasensitive assay of thyrotropin evaluated. Clin. Chem. 32 1 (1986) 88-92
5. Cook S.E., Nebes R.D., and Halligan E.M. Memory impairment in elderly individuals with a mildly elevated serum TSH: the role of processing resources, depression and cerebrovascular disease. Aging Neuropsychol. Cogn. 9 3 (2002) 175-183
6. Copeland J.R., Dewey M.E., and Griffiths-Jones H.M. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol. Med. 16 (1986) 89-99
7. De Jager C.A., Hogervorst E., Combrinck M., and Budge M.M. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol. Med. 33 6 (2003) 1039-1050
8. De Jong J.F., den Heijer T., Visser T.J., de Rijke Y.B., Drexhage H.A., Hofman A., and Breteler M.M.B. Thyroid hormones, dementia and atrophy of the medial temporal lobe. J. C. E. M. 91 7 (2006) 2569-2573
9. Demers, L.M., Spencer, C.A., 2002. NACB, Biochemistry TNAoC, Laboratory Medicine Practice Guidelines Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. available via http://www.nacb.org/lmpg/thyroid_LMPG_PDF.stm.
10. Dietlein M., Moka D., Schmidt M., Theissen P., and Schicha H. Prevention, screening and therapy of thyroid diseases and their cost-effectiveness. Nuklearmedizin. 42 5 (2003) 181-189
11. Dobert N., Hamscho N., Menzel C., Peters J., Frölich L., Tsolakis A., Zaplatnikov K., Kratzsch T., Diener J., Maurer K., and Grünwald F. Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET. Acta Med. Austriaca. 30 5 (2003) 130-133
12. Dorr M., and Volzke H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol. 30 4 (2005) 199-216
13. Faldt R., Passant U., Nilsson K., Wattmo C., and Gustafson L. Prevalence of thyroid hormone abnormalities in elderly patients with symptoms of organic brain disease. Aging 8 5 (1996) 347-353
14. Fisher D.A. Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clin. Chem. 42 1 (1996) 135-139
15. Folstein M., Folstein S., and McHugh P. 'Mini-mental State': a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12 (1977) 189-198
16. Gomez J.M., Aguilar M., Navarro M.A., Ortola J., and Soler J. Secretion of growth hormone and thyroid-stimulating hormone in patients with dementia. Clin. Invest. 72 7 (1994) 489-493
17. Gussekloo J., van Exel E., de Craen A.J., Meinders A.E., Frolich M., and Westendorp R.G. Thyroid status, disability and cognitive function, and survival in old age. JAMA 292 21 (2004) 2591-2595
18. Hogervorst E., Mendes Ribeiro H., Molyneux A., Budge M., and Smith A.D. Serum homocysteine, cerebrovascular risk factors and white matter low attenuation on CT scans in patients with post-mortem confirmed AD. Arch. Neurol. 59 5 (2002) 787-793
19. Hogervorst E., Combrinck M., Lapuerta P., Rue J., Swales K., and Budge M. The Hopkins Verbal Learning Test and screening for dementia. Dementia 13 1 (2002) 13-20
20. Hogervorst E., Bandelow S., Combrinck M., Irani S.R., and Smith A.D. The validity and reliability of 6 sets of overt criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach. Dementia 16 3 (2003) 170-180
21. Huppert F.A., and Kopelman M.D. Rates of forgetting in normal ageing: a comparison with dementia. Neuropsychologia 27 6 (1989) 849-860
22. Huppert F.A., Cabelli S.T., Matthews F., and MRC CFAS. Brief cognitive assessment in a UK population sample-distributional properties and the relationship between the MMSE and an extended mental state examination. BMC Geriatr. 5 (2005) 7
23. Jones S., Small B.J., Fratiglioni L., and Backman L. Predictors of cognitive change from preclinical to clinical Alzheimer's disease. Brain Cogn. 49 2 (2002) 210-213
24. Kalmijn S., Mehta K.M., Pols H.A.P., Hofman A., Drexhage H.A., and Breteler M.M.B. Subclinical hyperthyroidism and the risk of dementia, The Rotterdam study. Clin. Endocrinol. 53 (2000) 733-737
25. Miller K.J., Parsons T.D., Whybrow P.C., van Herle K., Rasgon N., van Herle A., Martinez D., Silverman D.H., and Bauer M. Memory improvement with treatment of hypothyroidism. Int. J. Neurosci. 116 8 (2006) 895-906
26. MRC CFAS Group. Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol. Med. 28 2 (1998) 319-335
27. Pasquini J.M., and Adamo A.M. Thyroid hormones and the central nervous system. Dev. Neurosci. 16 1-2 (1994) 1-8
28. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: overt characterization and outcome. Arch. Neurol. 56 (1999) 303-308
29. Pinto E.M., Huppert F.A., Morgan K., and Brayne C. Neutrophil counts, monocyte counts and cardiovascular disease in the elderly. Exp. Gerontol. 39 4 (1998) 615-619
30. Prinz P.N., Scanlan J.M., Vitaliano P.P., Moe K.E., Borson S., Toivola B., Merriam G.R., Larsen L.H., and Reed H.L. Thyroid hormones: Positive relationships with cognition in healthy, euthyroid older men. J. Gerontol. Ser. A. Biol. Sci. Med. 4 3 (1999) M111-M116
31. Stuerenburg H.J., Arlt S., and Mueller-Thomsen T. Free thyroxine, cognitive decline and depression in Alzheimer's disease. Neuro. Endocrinol. Lett. 27 4 (2006) 535-537
32. Sunderland T., Tariot P.N., Mueller E.A., Newhouse P.A., Murphy D.L., and Cohen R.M. TRH stimulation test in dementia of the Alzheimer type and elderly controls. Psychiatry Res. 16 4 (1985) 269-275
33. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., Franklyn J.A., Hershman J.M., Burman K.D., Denke M.A., Gorman C., Cooper R.S., and Weissman N.J. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 2 (2004) 228-238
34. Townsend P. Poverty in the United Kingdom (1979), Pelican, U.K.
35. Van Boxtel M.P., Menheere P.P., Bekers O., Hogervorst E., and Jolles J. Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology 29 7 (2004) 891-898
36. Van Duijn C.M., and Hofman A. Risk factors for Alzheimer's disease: The EURODEM collaborative re-analysis of case-control studies. Neuroepidemiol. 11 (1992) 106-113
37. Van Osch L.A., Hogervorst E., Combrinck M., and Smith A.D. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 61 11 (2004) 1967-1971
38. Vogel A., Elberling T.V., Hording M., Dock J., Rasmussen A.K., Feldt-Rasmussen U., Perrild H., and Waldemar G. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology 32 1 (2007) 36-43
39. Volpato S., Guralnik J.M., Fried L.P., Remaley A.T., Cappola A.R., and Launer L.J. Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58 (2002) 1055-1061
40. Wahlin A., Wahlin T.B.R., Small B.J., and Backman L. Influences of thyroid stimulating hormone on cognitive functioning in very old age. J. Gerontol. Ser. B. Psychol. Sci. 53 4 (1998) P234-P239
41. Wahlin A., Bunce D., and Wahlin T.B. Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology 30 7 (2005) 625-637
42. Wechsler, D., 1987. Wechsler Memory Scales-revised. Psychological Corporation, San Antonio.
43. Wilkins T.A., Midgley J.E., and Barron N. Comprehensive study of a thyroxine analogue. Clin. Chem. 34 (1985) 1644-1653